Form 8-K - Current report:
SEC Accession No. 0001641172-25-010514
Filing Date
2025-05-15
Accepted
2025-05-15 07:30:12
Documents
15
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 30318
2 EX-99.1 ex99-1.htm EX-99.1 128528
3 GRAPHIC ex99-1_001.jpg GRAPHIC 12748
  Complete submission text file 0001641172-25-010514.txt   361874

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abeo-20250515.xsd EX-101.SCH 3044
5 XBRL LABEL FILE abeo-20250515_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE abeo-20250515_pre.xml EX-101.PRE 22378
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3675
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 25948714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)